Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms 111-IN DAC |
Target- |
Action enhancers |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Lung Cancer | Phase 1 | United States | 02 Jul 2002 | |
Neoplasm Metastasis | Phase 1 | United States | 02 Jul 2002 | |
Non-Small Cell Lung Cancer | Phase 1 | United States | 02 Jul 2002 | |
Brain Cancer | Phase 1 | United States | 02 Jul 2002 | |
Breast Cancer | Phase 1 | United States | 28 Jun 2002 | |
Lung Cancer | Phase 1 | - | - |